SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- Nektar Therapeutics
(Nasdaq: NKTR) will announce its financial results for the third
quarter 2020 on Thursday, November 5,
2020, after the close of U.S.-based financial markets.
Howard Robin, President and Chief
Executive Officer, will host a conference call to review the
results beginning at 5:00 p.m. Eastern
Time/2:00 p.m. Pacific
Time.
The press release and live audio-only webcast of the conference
call can be accessed through a link that is posted on the Home Page
and Investors section of the Nektar website:
http://ir.nektar.com/. The web broadcast of the conference
call will be available for replay through Tuesday, December 1, 2020.
To access the conference call, follow these instructions:
Dial: (877) 881-2183
(U.S.); (970) 315-0453 (international)
Conference ID: 5192707 (Nektar Therapeutics is the
host)
About Nektar Therapeutics
Nektar Therapeutics is a
biopharmaceutical company with a robust, wholly owned R&D
pipeline of investigational medicines in oncology and immunology as
well as a portfolio of approved partnered medicines. Nektar is
headquartered in San Francisco,
California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about
the company and its drug development programs and capabilities may
be found online at http://www.nektar.com.
Contacts:
For Investors:
Jerry
Isaacson of Nektar Therapeutics - 628-895-0634
Vivian Wu of Nektar Therapeutics -
628-895-0661
View original
content:http://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-2020-on-thursday-november-5-2020-after-close-of-us-based-financial-markets-301162089.html
SOURCE Nektar Therapeutics